Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check4 days agoChange DetectedAdded revision: v3.4.3; removed revision: v3.4.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a new revision note: Revision: v3.4.2; the funding-status notice and the previous revision (v3.4.1) were removed.SummaryDifference0.5%

- Check39 days agoChange DetectedAdded a government funding lapse notice and updated the site to revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check46 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' field in Study Record Dates, and updated the footer to show 'No FEAR Act Data' and 'Revision: v3.4.0' (replacing 'No FEAR Act data' and 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor revision note with no impact on the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedFooter updates include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link, with the prior Revision: v3.3.2 entry deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.